This monograph provides a comprehensive approach to addressing the injection drug user's (IDUs) role in the HIV epidemic and recommends strategies for community groups, agencies, and providers to help reduce the IDU's sexual and drug-use risks of HIV transmission.
This report provides updated data on the incidence and prevalence of HIV/AIDS in the United States resulting from anonymous unlinked surveys conducted by health clinics in selected metropolitan areas. Included in this report are summaries of data from January 1993 through December 1977 from unlinked prevalence surveys conducted in selected STD clinics, drug treatment centers (DTCs), and adolescent medicine clinics, as well as data from HIV screening programs for entrants in the Job Corps, military service, and first-time blood donors.
This MMWR provides revised guidelines for HIV counseling, testing, and referral (CTR) and revised recommendations for HIV screening of pregnant women. It encourages the availability of anonymous and confidential HIV testing and informed, voluntary, and consented HIV testing; access to testing and effective provision of test results; and using a prevention counseling approach aimed at personal risk reduction for HIV-infected persons and persons at increased risk for HIV infection.
This report presents the results of a study by Funders Concerned About AIDS (FCAA) called the Funder Remobilization Project (FRP), which was designed to develop a clearer understanding of the current state of human HIV/AIDS philanthropy in order to motivate and activate an ongoing vigorous philanthropic response. The report discusses the purpose of the study, research methods, the environment for HIV/AIDS philanthropy in the 21st century, FRP findings including challenges and opportunities in moving forward in HIV/AIDS philanthropy, and a framework for ongoing philanthropic leadership.
This information sheet discusses the benefits and challenges surrounding physician prescription of sterile syringes for injection drug users (IDUs). The benefits include substantially reducing IDUs' risk of acquiring or transmitting the HIV, hepatitis B and C, and other blood-borne infections. The challenges include legal and attitudinal issues. It examines the results of a research study in Rhode Island examining the feasibility of physician prescription in a community care setting.
This information sheet presents basic information for injecting drug users (IDUs) on disinfection, especially bleach disinfection, of drug injection equipment to reduce the risk of getting or transmitting HIV or HCV.
This information sheet is a letter informing the recipient that the CDC recommends that all states and territories adopt confidential name-based surveillance systems to report HIV infection. The letter notes that 43 states and local health departments use confidential name-based reporting while 14 states and local health departments use code-based or name-to code methods.
This information sheet discusses the TB Genotyping Information Management System (TB GIMS) a secure web-based system for storing and managing genotyping data on TB patients in the United States. It explains the objectives of TB GIMS, who would be the primary users, and the different user roles and access levels. Users are categorized as super user, standard user, and restricted-access user.
This report is a white paper outlining the Centers for Disease Control and Prevention’s (CDC) National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention’s (NCHHSTP) vision for program collaboration and service integration (PCSI). The white paper defines and articulates a framework for conceptualizing PCSI. It identifies how NCHHSTP will work with internal and external stakeholders to accomplish the goals; outlines key measures to monitor and evaluate progress; and describes how NCHHSTP will work with partners at national, state, and local levels to advance PCSI.
This study discusses information on the 184 syringe exchange programs (SEPs) operating in 36 states, the District of Columbia, and Puerto Rico. Of these SEPs, 67% completed a mail/telephone survey conducted by North American Syringe Exchange Network (NASEN) and Beth Israel Medical Center, New York, which covered program operations for 2008. The report summarizes findings from the survey and compares them with results from a previous SEP survey for 1994-2007.